Fundraising Foxリジェネフロ
Kyoto, JP · 4 known investors
Find your way into リジェネフロ
Sign up to see every warm intro you have to リジェネフロ
- Paths you didn't know you had: your email and LinkedIn already hold routes to the リジェネフロ team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rege Nephro develops regenerative medicine therapies for kidney disease, focusing on nephron progenitor cell research and differentiation from iPS cells. The company aims to commercialize treatments for patients with kidney disorders and reduce reliance on dialysis and transplantation.
Investors · 4
Related companies · 1
Companies working in the same space as リジェネフロ.
Frequently asked questions
- What does リジェネフロ do?
- Rege Nephro develops regenerative medicine therapies for kidney disease, focusing on nephron progenitor cell research and differentiation from iPS cells. The company aims to commercialize treatments for patients with kidney disorders and reduce reliance on dialysis and transplantation.
- Who are リジェネフロ's investors?
- リジェネフロ's investors include Global Brain, Kyoto University Innovation Capital, Nippon Venture Capital, TOHOKU University Venture Partners.
- Where is リジェネフロ headquartered?
- リジェネフロ is headquartered in Kyoto, JP.